SAPC ASM 2024 - Bristol - Talk Abstracts

Back to SAPC ASM 2024 - Bristol

  1. 10D.3
    The role of social prescribing in Medication Review and Deprescribing (SPiDeR)
  2. 10D.5
    Structured Medication Review Storylines: an interpretive policy analysis of medicines optimisation policy in primary care.
  3. 10D.6
    How did patients feel about their medication review? Patient-reported satisfaction of medication reviews as part of a complex intervention for polypharmacy in general practice: IMPPP Trial
  4. 10E.1
    Rethinking continuity in general practice for people with mesothelioma
  5. 10E.2
    How can the whole practice approach to training and education foster a healthy system in facilitating early cancer diagnosis in primary care? Qualitative findings from a feasibility RCT.
  6. 10E.3
    Are there gender inequalities between ethnic groups in primary care cancer referrals?
  7. 10E.5
    A case control study of clinical factors associated with ovarian cancer in a younger population with high rates of migration, deprivation and ethnic diversity.
  8. 10F.1
    Prevalence of anaemia in primary care in England
  9. 10F.2
    Communicating blood test results in primary care: a mixed methods systematic review
  10. 10F.3
    Natriuretic peptide testing to detect left ventricular systolic dysfunction in the OxVALVE cohort: diagnostic accuracy study
  11. 10F.5
    General Practitioner Access to Diagnostic Imaging: A Scoping Review of Associated Challenges
  12. 10F.6
    Public acceptability of self-sampling and self-testing for infections: a rapid systematic review
  13. 10G.1
    OPTIMISING THE IMPACT OF YOUR RESEARCH: A BYOP WORKSHOP
  14. 12A.1
    Diagnostic accuracy of Prostate Specific Antigen (PSA) for prostate cancer detection in primary care: the ProsDetect study
  15. 12A.2
    Using realist approaches to explain and understand the optimal use of paramedics in primary care.
  16. 12A.3
    Understanding the determinants and implementation strategies for risk of frailty management in primary care in Australia
  17. 1A.1
    The Immune Defence study: a randomised trial evaluating nasal sprays and behavioural intervention approaches to reduce respiratory infections in primary care
  18. 1A.2
    Implementation of point-of-care tests in European primary care: a qualitative process evaluation with patients and clinicians in six countries
  19. 1A.3
    A realist analysis of patient and clinician views and experiences in the randomised controlled efficacy trial of rapid respiratory microbiological point-of-care-testing in primary care (the RAPID-TEST RCT)
  20. 1A.5
    Exploring the role and implementation of Acute Respiratory Infection (ARI) Hubs in England: a qualitative study

Pages